Torna indietro

Pubblicazioni Organo: Fegato e Pancreas

T.J. Vogl, A.Hagar, N.E. A. Nour-Eldein, T. Gruber-Rouh, K. Eicher, H. Ackermann, W.O. Bechstein and N.N.N. Naguib. High Frequency versus Low Frequency Microwave Ablation in Malignant Liver Tumors: Evaluation of Local Tumour Control and Survival. Int. Journal of Hyperthermia (Jul 2016)

https://pubmed.ncbi.nlm.nih.gov/27406062/

Medhat E, Abdel Aziz A, Nabeel M, et al. Value of microwave ablation in treatment of large lesions of hepatocellular carcinoma. J Dig Dis. 2015;16(8):456-463. doi:10.1111/1751-2980.12259

https://pubmed.ncbi.nlm.nih.gov/25958973/

Cillo U, Bertacco A, Fasolo E, Carandina R, Vitale A, Zanus G, Gringeri E, D’Amico F, Bassi D, Neri D, Dadduzio V, Farinati F, Aliberti C. Videolaparoscopic microwave ablation in patients with HCC at a European high-volume center: Results of 815 procedures. J Surg Oncol. 2019 Nov;120(6):956-965. doi: 10.1002/jso.25651. Epub 2019 Aug 1. PubMed PMID: 31373009.

https://pubmed.ncbi.nlm.nih.gov/31373009/

Darweesh SK, Gad AA. Percutaneous microwave ablation for HCV-related hepatocellular carcinoma: Efficacy, safety, and survival. Turk J Gastroenterol. 2019 May;30(5):445-453. doi: 10.5152/tjg.2019.17191. PubMed PMID: 31060999; PubMed Central PMCID: PMC6505648.

https://pubmed.ncbi.nlm.nih.gov/31060999/

Claudio Pusceddu, Luca Melis, Nicola Ballicu, Barbara Sotgia, Marcovalerio Melis, Valeria Sanna, Giovanni Battista Meloni, Alberto Porcu, Alessandro Fancellu: Percutaneous Microwave Ablation Under CT Guidance for Hepatocellular Carcinoma: a Single Institutional Experience. J Gastrointest Cancer (2017)

https://pubmed.ncbi.nlm.nih.gov/28530021/

S. Thamtorawat, R.M. Hicks, Jenifer Yu, S. Siripongsakum, Wei-chan Lin, Steven S. Raman, Justin P. McWilliams, Michael Douek, Simin Bahrami and David S.K. Lu. Preliminary Outcome of MWA of HCC: Breaking the 3-cm Barrier? JVIR (2016)

https://pubmed.ncbi.nlm.nih.gov/27013403/

Filippiadis DK, Spiliopoulos S, Konstantos C, et al. Computed tomography-guided percutaneous microwave ablation of hepatocellular carcinoma in challenging locations: safety and efficacy of high-power microwave platforms. Int J Hyperthermia. 2018;34(6):863-869. doi:10.1080/02656736.2017.1370728

https://pubmed.ncbi.nlm.nih.gov/28828899/

A. Veltri, C. Gazzera, M. Calandri, F. Marenco, A. Doriguzzi Breatta, P. Fonio, G. Gandini. Percutaneous treatment of HCC exceeding 3 cm/ combined therapy or MWA: Preliminary results. Radiol Med (May 2015)

https://pubmed.ncbi.nlm.nih.gov/26025419/

G. Poggi, B. Montagna, P. Di Cesare, G. Riva, G. Bernardo, M. Mazzucco, A. Riccardi. Microwave Ablation of Hepatocellular Carcinoma Using a New Percutaneous Device: Preliminary Results. Anticancer Res. (2013 Mar; 33(3):1221-1227)

https://pubmed.ncbi.nlm.nih.gov/23482806/

Cillo U, Vitale A, Dupuis D, Corso S, Neri D, D’Amico F, Gringeri E, Farinati F, Vincenzi V, Zanus G. Laparoscopic ablation of hepatocellular carcinoma in cirrhotic patients unsuitable for liver resection or percutaneous treatment: a cohort study. PLoS One. 2013;8(2):e57249. doi: 10.1371/journal.pone.0057249. Epub 2013 Feb 21. PubMed PMID: 23437351; PubMed Central PMCID: PMC3578795.

https://pubmed.ncbi.nlm.nih.gov/23437351/